Related Experiment Video
Updated: Aug 9, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
[Tuberculosis in patients with HIV infection]
Tuberculosis in HIV patients presents varied clinical courses based on immunodeficiency stage. Prophylaxis with isoniazid or rifampicin is recommended for HIV-infected individuals with immunodeficiency.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Context:
- Observational study of 16 tuberculosis cases in HIV-infected patients between 1987-1995.
- Tuberculosis represented 26.7% of AIDS patients treated, with diverse clinical presentations.
- Diagnosis was primarily intravital (14 cases) with a significant mortality rate.
Purpose:
- To analyze the clinical course and outcomes of tuberculosis in HIV-infected patients.
- To determine the relationship between immunodeficiency stage and tuberculosis presentation.
- To establish recommendations for tuberculosis prophylaxis in immunocompromised HIV patients.
Summary:
- Tuberculosis presentation and outcomes in HIV-infected individuals are strongly influenced by the degree of immunodeficiency.
- Moderate immunodeficiency (CD4 > 200/mm3) typically resulted in localized, treatable tuberculosis.
- Severe immunodeficiency (CD4 < 100/mm3) was associated with generalized, aggressive, and treatment-resistant tuberculosis.
Impact:
- Highlights the critical need for tuberculosis prophylaxis, such as isoniazid or rifampicin, in HIV-infected individuals.
- Informs clinical management strategies for tuberculosis in the context of HIV infection.
- Underscores the importance of monitoring CD4 counts to predict tuberculosis course and treatment response.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
07:21Processing of Bronchoalveolar Lavage Fluid and Matched Blood for Alveolar Macrophage and CD4+ T-cell Immunophenotyping and HIV Reservoir Assessment
Published on: June 23, 2019
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis